ABVC BIOPHARMA, INC. Logo

ABVC BIOPHARMA, INC.

Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.

ABVC | NDAQ

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
44370 OLD WARM SPRINGS BLVD., 94538 FREMONT
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company developing drugs and medical devices for unmet medical needs. The company specializes in botanical, plant-based therapies designed for high efficacy and low toxicity. Its development pipeline targets conditions in ophthalmology, oncology, and Central Nervous System (CNS) disorders, including major depressive disorder and adult ADHD. Key products in development include Vitargus®, a biodegradable vitreous replacement, and novel treatments for depression (ABV-1504) and ADHD (ABV-1505). The company in-licenses promising compounds from a global network of research institutions to advance them through clinical trials. Additionally, its subsidiary, BioKey, Inc., provides contract development and manufacturing services for nutritional and pharmaceutical products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ABVC BIOPHARMA, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ABVC BIOPHARMA, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ABVC BIOPHARMA, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America ABSI
Acrivon Therapeutics, Inc. Logo
Develops precision cancer therapies by matching patients to drugs using its proteomics platform.
United States of America ACRV

Talk to a Data Expert

Have a question? We'll get back to you promptly.